[Evaluation and spatial-temporal variations of ecological comprehensive index along the Yellow River of Shanxi Province, China]. / 山西省沿黄地区生态综合指数评价及时空变化.

Ecological comprehensive index can quantitatively and visually analyze the temporal and spatial variations of ecological environment quality in a region. Based on the five indices of fractional vegetation coverage, leaf area index, total primary productivity, land surface temperature and wetness obtained by MODIS satellite data in 2001, 2005, 2010, 2015 and 2020, and coupled the comprehensive quality of the eco-environment (K), we analyzed the temporal and spatial variations of ecological quality along the Yellow River of Shanxi Province from 2001 to 2020 by using the principal component analysis and spatial autocorrelation method. The results showed that the mean value of K in the study area increased from 0.3354 to 0.4389 during 2001-2020. The ecological quality along the Yellow River of Shanxi Province improved overall, but with obvious temporal and spatial variations. On the large scale, it presented a pattern of "better in the south and worse in the north". There was difference between hills and mountains on the small scale. It showed a trend of continuous improvement in time, but the rate of change was different. The trend of improvement in the south was stronger than that in the north. From 2001 to 2020, the global Moran I values of K were all greater than 0.93, indicating that the ecological quality along the Yellow River of Shanxi Province had a strong spatial correlation. The types of spatial agglomeration were mainly high-high and low-low. The high-high agglomeration areas were mainly distributed in blocks in the south, while the low-low agglomeration areas were mainly concentrated in the north. The ecological quality of areas alone the Yellow River of Shanxi Province had been greatly improved during the research period, but there was still obvious spatial heterogeneity, which need to strengthen ecological protection.

Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.

Cardiac hypertrophy causes heart failure and is associated with hyperglycemia in patients with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts beneficial effects in patients with heart failure. In this study, we explored the effects and mechanism of mibefradil on high-glucose-induced cardiac hypertrophy in H9c2 cells. H9c2 cells were incubated in a high-glucose medium and then treated with different concentrations of mibefradil in the presence or absence of the Akt inhibitor MK2206 or mTOR inhibitor rapamycin. Cell size was evaluated through immunofluorescence, and mRNA expression of cardiac hypertrophy markers (atrial natriuretic peptide, brain natriuretic peptide, and ß-myosin heavy chain) was assessed by using quantitative real-time polymerase chain reaction. Changes in the expression of p-PI3K, p-Akt, and p-mTOR were evaluated using Western blotting, and autophagosome formation was detected using transmission electron microscopy. Our results indicate that mibefradil reduced the size of H9c2 cells, decreased mRNA expression of atrial natriuretic peptide, brain natriuretic peptide, and ß-myosin heavy chain, and decreased the level of autophagic flux. However, MK2206 and rapamycin induced autophagy and reversed the effects of mibefradil on high-glucose-induced H9c2 cells. In conclusion, mibefradil ameliorated high-glucose-induced cardiac hypertrophy by activating the PI3K/Akt/mTOR pathway and inhibiting excessive autophagy. Our study shows that mibefradil can be used therapeutically to ameliorate cardiac hypertrophy in patients with diabetes mellitus.